ClinicalTrials.govpublic full text
A Study of GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS Mutation
advanced solid tumors cancer, pancreatic ductal adenocarcinoma, ras mutation, gfh276, pdac, solid tumors, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 882960
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.